Class III

Latest Articles

Article
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
Lana Zhovtis Ryerson, John Foley, Ih Chang, et al.

Neurology September 12, 2019
Editorial
Do good things come to those who wait?Dosing interval of natalizumab in MS
David B. Clifford, Kenneth L. Tyler

Neurology September 12, 2019
Research
Machine learning as a diagnostic decision aid for patients with transient loss of consciousness
Alistair Wardrope, Jenny Jamnadas-Khoda, Mark Broadhurst, et al.

Neurology: Clinical Practice September 06, 2019
Article
Urodynamic study for distinguishing multiple system atrophy from Parkinson disease
Jung Hyun Shin, Kye Won Park, Kyeong Ok Heo, et al.

Neurology August 01, 2019